A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee

Trial Profile

A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 27 Jul 2017

At a glance

  • Drugs Hyaluronic acid/triamcinolone (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Anika Therapeutics
  • Most Recent Events

    • 27 Jul 2017 New trial record
    • 26 Jul 2017 According to an Anika Therapeutics media release, the results of this trial have been published in the journal Cartilage.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top